High Intensity Focused Ultrasound Therapy Market Share

Global High Intensity Focused Ultrasound (HIFU) Therapy Market Overview

High Intensity Focused Ultrasound (HIFU) Therapy Market Size was valued at USD 0.1 Billion in 2022. The High Intensity Focused Ultrasound (HIFU) Therapy market End User is projected to grow from USD 0.11 Billion in 2023 to USD 0.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.50% during the forecast period (2023 - 2032). Prostate cancer incidence is rising along with the number of cases of neurological conditions, the use of HIFU in treating those conditions, and the number of cases of neurological conditions overall, are the key market drivers enhancing the market growth.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

High Intensity Focused Ultrasound (HIFU) Therapy Market Trends

• Increasing cases of neurological disorders is driving the market growth

Because HIFU is being used more frequently to treat neurological problems, rising occurrences of neurological illnesses could fuel market expansion over the forecast period. For instance, The Lancet reported in July 2021 that the prevalence of non-communicable neurological illnesses increased ly between 1990 to 2019. By 2019, noncommunicable neurological disorders accounted for 8.2% of all diseases worldwide, up from 0.4% in 1990.

Since HIFU is used to treat prostate cancer, an increase in the prevalence of the disease is anticipated to fuel market expansion throughout the forecast period. For instance, the American Society of Clinical Oncology estimates that 1,414,259 men were given prostate cancer diagnoses throughout the world in February 2022. North America is anticipated to be the most dominant area. Thus, driving the High Intensity Focused Ultrasound (HIFU) Therapy market revenue.

High Intensity Focused Ultrasound (HIFU) Therapy Market Segment Insights

High Intensity Focused Ultrasound (HIFU) Therapy Method Insights

The High Intensity Focused Ultrasound (HIFU) Therapy market segmentation, based on method, includes non-invasive method and minimal invasive method. Minimal invasive method segment dominated the market in 2022. This can be ascribed to the method's rising popularity as a result of its accessibility and efficacy.

High Intensity Focused Ultrasound (HIFU) Therapy Application Insights

The High Intensity Focused Ultrasound (HIFU) Therapy market segmentation, based on application, includes prostate cancer, uterine fibroids, neurological disorders, cosmetic medicine, and others. Prostate cancer segment dominated the  High Intensity Focused Ultrasound (HIFU) Therapy market in 2022. The growing use of High-Intensity Focused Ultrasound (HIFU) for the treatment of different cancers and tumour types is blamed for this.

High Intensity Focused Ultrasound (HIFU) Therapy End User Insights

The High Intensity Focused Ultrasound (HIFU) Therapy market segmentation, based on end user, includes diagnostic centers, hospitals, research centers, and others. Hospitals segment dominated the market in 2022. This is a result of HIFU use in hospital oncology departments.

Figure 1 High Intensity Focused Ultrasound (HIFU) Therapy Market, by End User, 2022 & 2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

High Intensity Focused Ultrasound (HIFU) Therapy Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America High Intensity Focused Ultrasound (HIFU) Therapy Market dominated this market in 2022 (45.80%). This is due to an increase in the occurrence of neurological illnesses and cancers like lung, breast, and prostate cancer. The American Cancer Society estimates that 40,610 Americans died in 2017 as a result of breast cancer. The demand for the worldwide high intensity focused ultrasound market in North America is increasing due to a few benefits provided by high intensity focused beam, such as improved safety, short hospital stays, quicker recovery, and higher accuracy. Further, the U.S. High Intensity Focused Ultrasound (HIFU) Therapy market held the largest market share, and the Canada High Intensity Focused Ultrasound (HIFU) Therapy market was the fastest growing market in the North America region.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) THERAPY MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe High Intensity Focused Ultrasound (HIFU) Therapy market accounted for the healthy market share in 2022. This is due to rising R&D expenditures and a rise in public knowledge of disease diagnosis. Furthermore, because the developed markets are somewhat saturated, this region offers extraordinary chances for investors and venture capitalists. Further, the German High Intensity Focused Ultrasound (HIFU) Therapy market held the largest market share, and the U.K High Intensity Focused Ultrasound (HIFU) Therapy market was the fastest growing market in the European region

The Asia Pacific High Intensity Focused Ultrasound (HIFU) Therapy market is expected to register significant growth from 2023 to 2032. This is due to rising cancer incidence and government funding for research and development. Moreover, China’s High Intensity Focused Ultrasound (HIFU) Therapy market held the largest market share, and the Indian High Intensity Focused Ultrasound (HIFU) Therapy market was the fastest growing market in the Asia-Pacific region.

High Intensity Focused Ultrasound (HIFU) Therapy Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the High Intensity Focused Ultrasound (HIFU) Therapy market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their  footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, High Intensity Focused Ultrasound (HIFU) Therapy Industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the High Intensity Focused Ultrasound (HIFU) Therapy Industry to benefit clients and increase the market sector. In recent years, the High Intensity Focused Ultrasound (HIFU) Therapy Industry has offered some of the most significant advantages to medicine. Major players in the High Intensity Focused Ultrasound (HIFU) Therapy market, including Guided Therapy, EDAP TMS, SonaCare Medical LLC, heraclion, Chongqing Haifu Medical Technology Co. Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD, Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS Instruments, are attempting to increase market demand by investing in research and development operations.

Koninklijke Philips NV (Philips) is a diversified technology company that develops and manufactures medical and consumer electronics products. The company offers goods and services in the following industries diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultrasound, monitoring and analytics, sleep and respiratory care, population health management, linked care informatics, and therapeutic care. There are items for skin, hair, and hair removal as well as power toothbrushes, brush heads, baby bottles, sterilisers, breast pumps, shavers, groomers, and trimmers. Additionally, it offers things for oral hygiene and personal care. The company conducts business in the Asia-Pacific area, Europe, and North America. North Brabant, Netherlands, is home to Philips' corporate headquarters.

Ultrasonic technology is used by the medical device company EDAP TMS SA (EDAP) in the development, production, and marketing of minimally invasive medical devices to treat a range of diseases, including urological ailments and other indications. It provides high intensity focused ultrasound (HIFU) equipment for prostate cancer treatment as well as extracorporeal shock-wave lithotripters (ESWL) for the treatment of urinary tract stones. The company produces ablatherm fusion, focused one, sonolith i-move, sonolith i-sys, and laserlith i-dust, among other things. The company distributes products to urology clinics, medical centres, and research organisations. Customers can also use the company's HIFU equipment through its HIFU mobile treatment services. The company sells medical equipment made by other companies, including micro-ultrasound machines and lasers. Through a direct sales force, representative offices, subsidiaries, and distributors, EDAP makes its products available in the Americas, Europe, the Middle East, and Asia. The EDAP headquarters are in Lyon, France's Vaulx-en-Velin. CMS authorised a new reimbursement code for HIFU prostate ablation, according to a May 2017 statement from EDAP.

Key Companies in the High Intensity Focused Ultrasound (HIFU) Therapy market include

• Guided Therapy


• EDAP TMS


• SonaCare Medical LLC


• heraclion


• Chongqing Haifu Medical Technology Co. Ltd


• Koninklijke Philips N.V.


• Shanghai A&S Co. LTD


• Mianyang Sonic Electronic Ltd.


• Insightec


• Alpinion Medical Systems


• FUS Instruments

High Intensity Focused Ultrasound (HIFU) Therapy Industry Developments

October 2018 A health company called The Baldan Group has introduced the HIFU Lab system, which focuses on issues with the face and body shape.

April 2016 In order to treat the neck and face by promoting collagen synthesis and regeneration, which results in lifting and tightening, Venn Healthcare introduced the ULTRAFORMER II and III.

High Intensity Focused Ultrasound (HIFU) Therapy Market Segmentation

High Intensity Focused Ultrasound (HIFU) Therapy Method Outlook

• Non-Invasive Method


• Minimal Invasive Method

High Intensity Focused Ultrasound (HIFU) Therapy Application Outlook

• Prostate Cancer


• Uterine Fibroids


• Neurological Disorders


• Cosmetic Medicine


• Others

High Intensity Focused Ultrasound (HIFU) Therapy End User Outlook

• Diagnostic Centers


• Hospitals


• Research Centers


• Others

High Intensity Focused Ultrasound (HIFU) Therapy Regional Outlook

• 
  North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America